冷泉港亚洲2012年会:表观遗传学、染色质与转录会议

Epigenetics, Chromatin & Transcription
Suzhou, China
April 23 – 27, 2012

Organizers:
Robert Martienssen, Cold Spring Harbor Laboratory, USA
Rui-Ming Xu, Institute of Biophysics, Beijing, China
Yi Zhang, HHMI/University of North Carolina at Chapel Hill, USA

We are pleased to announce the 2nd Cold Spring Harbor Asia Conference on Epigenetics, Chromatin & Transcription which will be held at the Suzhou Dushu Lake Conference Center in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday April 23, and will conclude after lunch on Friday, April 27, 2012. The meeting will include a combination of oral sessions and poster sessions, covering the latest findings across many topics in epigenetics and chromatin biology by bringing together a group of scientific leaders.

Major Topics:
- Chromatin and transcription regulation
- Chromatin domains and structure
- DNA methylation and demethylation
- Histone modifications
- Nucleosome remodeling and non-coding RNAs
- Epigenetics and stem cell reprogramming
- New techniques and new epigenetic phenomenons
- Epigenetics and human diseases

Registration available until April 23, 2012
The on-line registration will be available until the meeting starts. But early registration will help to save cost. Rates vary for corporate/industry, academic (PhD, MD, staff scientists) and student (up to PhD) attendees. Endowed student package costs as low as USD250/CNY1530 before Februrary 10th, 2012.

Abstracts due February 10th, 2012
We encourage abstracts to contain new and unpublished materials. Selection results for short talks (10-20) and poster presentations will be made by the organizers on the basis of scientific merit and relevance.

Fellowships of up to $500 (USD) are available to participants who have an abstract accepted for poster presentation.

Keynote Speakers
Ronald Evans, The Salk Institute, USA
Steven Henikoff, Fred Hutchinson Cancer Research Center, USA
Rudolf Jaenisch, Whitehead Institute/MIT, USA
Danny Reinberg, New York University, USA

Invited Speakers
Asifa Akhtar, Max-Planck-Institut fur Immunbiologie, Germany
Sung Hee Baek, Seoul National University, Korea
Marisa Bartolomei, University of Pennsylvania School of Medicine, USA
Howard Cedar, Hebrew University Hadassah Medical Center, Israel
Howard Chang, Stanford University, USA
Xuemei Chen, University of California Riverside, USA
Don Cleveland, University of California, San Diego, USA
Joseph Ecker, The Salk Institute for Biological Studies, USA
Kristian Helin, University of Copenhagen, Denmark
Steve Jacobsen, HHMI/University of California, USA
Robert Kingston, Mass General Hospital/Harvard Med School, USA
Marjori Matzke, Austrian Academy of Sciences, Austria
Huck-Hui Ng, Genome Institute of Singapore, Singapore
Dinshaw Patel, Memorial Sloan-Kettering Cancer Center, USA
Craig Peterson, University of Massachusetts, USA
Wolf Reik, The Babraham Institute, UK
Bing Ren, Ludwig Institute for Cancer Research, USA
Robert Roeder, The Rockefeller University, USA
Mitinori Saitou, Kyoto University, Japan
Hiroyuki Sasaki, Kyushu University, Japan
Dirk Schübeler, Friedrich Miescher Institute for Biomedical Research, Switzerland
Ali Shilatifard, Stowers Institute for Medical Research, USA
Yoichi Shinkai, Kyoto University, Japan
Robert Singer, Albert Einstein College of Medicine, USA
Davor Solter, Institute of Medical Biology, Singapore
Azim Surani, Wellcome/CRC Institute, UK
Alexander Tarakhovsky, The Rockefeller University, USA
Xiaoliang Sunney Xie, Harvard University, USA
Keji Zhao, NHLBI, NIH, USA
Bing Zhu, National Institute of Biological Sciences, China
Jian-Kang Zhu, Purdue University, USA